The burden of paying for specialty pharmacy drugs is a top concern for employers, compelling benefit advisers to take a more active role in their clients pharmacy benefit management and increasing the importance of the negotiating practices of pharmacy benefit managers.
Half of large employers say the cost of specialty pharmacy drugs is their second or third highest cost-driver, behind high-cost claims and special conditions, according to a recent survey by the National Business Group on Health. As employers consider their health plan designs, they "are very focused on specialty pharmacy drugs and the potential impact they have" on the company's bottom-line, says NBGH President Brian Marcotte.
Register or login for access to this item and much more
All Employee Benefit Adviser content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access